Development of a genetically-modified novel T-cell receptor for adoptive cell transfer against renal cell carcinoma
- 19 January 2011
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 366 (1-2) , 43-51
- https://doi.org/10.1016/j.jim.2011.01.002
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Cancer Institute
This publication has 26 references indexed in Scilit:
- Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigenBlood, 2009
- Increasing functional avidity of TCR-redirected T cells by removing defined N-glycosylation sites in the TCR constant domainThe Journal of Experimental Medicine, 2009
- Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative RegimensJournal of Clinical Oncology, 2008
- Evolutionarily Conserved Amino Acids That Control TCR-MHC InteractionAnnual Review of Immunology, 2008
- Enhanced Antitumor Activity of T Cells Engineered to Express T-Cell Receptors with a Second Disulfide BondCancer Research, 2007
- Cancer Regression in Patients After Transfer of Genetically Engineered LymphocytesScience, 2006
- Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic MelanomaJournal of Clinical Oncology, 2005
- Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide–based retroviral vectorNature Biotechnology, 2004
- Randomized Study of High-Dose and Low-Dose Interleukin-2 in Patients With Metastatic Renal CancerJournal of Clinical Oncology, 2003
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesScience, 2002